Eloxx Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Eloxx Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ELOX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001035354
Board of directors
-
Alan Edmund Walts · DirectorSince 2023
-
Lindsay Androski · DirectorSince 2023
-
Nina S. Kjellson · DirectorSince 2026
-
Stephen W. Webster · DirectorSince 2026
- Since 2023
-
Sumit Aggarwal · Director · President and CEOSince 2023
-
Tomer Kariv · DirectorSince 2023
Chief executives
Sumit Aggarwal
· PRESIDENT AND CEO
Dates unknown
Board connections
5 of this board's directors also sit on 10 other boards.
- via Lindsay Androski
- via Steven D. Rubin
- via Stephen W. Webster
- via Steven D. Rubin
- via Tomer Kariv
- via Stephen W. Webster
- via Steven D. Rubin
- via Steven D. Rubin
- via Steven D. Rubin
- via Nina S. Kjellson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Domicilium Real Estate Fund III LP 10% owner | Other | +238,422 | — | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP 10% owner | Other | +361,578 | — | — |
| May 27, 2026 | Domicilium Real Estate Fund III LP 10% owner | Other | −113,636 | — | — |
| May 27, 2026 | Coastlands Capital LP 10% owner | Other | −1,250,000 | — | — |
| Feb 28, 2026 | Sumit Aggarwal Director, Officer (President and CEO), 10% owner | Option exercise | +260,946 | $0.15 | $39,142 |
| Jan 24, 2026 | Steven D. Rubin Director | Option exercise | +1,875 | — | — |
| Jan 24, 2026 | Alan Edmund Walts Director | Option exercise | +1,875 | — | — |
| Jan 24, 2026 | Sumit Aggarwal Director, Officer (President and CEO), 10% owner | Option exercise | +15,000 | — | — |
| Sep 19, 2025 | Sumit Aggarwal Director, Officer (President and CEO), 10% owner | Grant or award | +1,000,000 | — | — |
| Aug 14, 2025 | Sumit Aggarwal Director, Officer (President and CEO), 10% owner | Option exercise | +196,880 | — | — |
| Jan 24, 2025 | Sumit Aggarwal Director | Option exercise | +30,000 | — | — |
| Jan 24, 2025 | Steven D. Rubin Director | Option exercise | +3,750 | — | — |
| Jan 24, 2025 | Lindsay Androski Director | Option exercise | +3,750 | — | — |
| Jan 24, 2025 | Alan Edmund Walts Director | Option exercise | +3,750 | — | — |
| Oct 16, 2024 | Alan Edmund Walts Director | Grant or award | +12,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.